TRENDING :  Market Movers  |  Top 50   AAPL (-0.57%)    TSLA (-3.75%)    TVIX (1.55%)    QURE (2.34%)    QQQ (-0.37%)    QCOM (-0.2%)    PSTG (1.46%)    PEI (-1.96%)    PAH (0%)    MCD (1.29%)    KO (1.69%)    JPM (-0.21%)    IVC (-7.29%)    IMDZ (309.86%)    GS (-1.13%)    GOOGL (-1.47%)    FUV (-2.18%)    FDX (0.21%)    FCEL (-34.08%)    FB (-1.56%)    EA (-1.8%)    CRM (0.69%)    CBS (-0.55%)    BILI (-0.93%)    BIDU (0.37%)

 ABT - Abbott Laboratories

$75.14 [-0.41][-0.53%]

Next Earnings



Trade Idea »


Quarterly Rating Chart


1=Strong Buy, 2=Buy, 3=Hold, 4=Underperform, 5=Sell
Price Targets
High $83.00
Low $68.00
Average $79.20
Current $75.14

CompanyAnalyst NamePT ActionActionRatingTargetDate
Credit SuisseAnnouncesInitiates Coverage OnStrong Buy$82.0012/18/18
Morgan StanleyDavid LewisRaisesMaintainsStrong Buy$82.0012/04/18
Goldman SachsIsaac RoRaisesUpgradesBuy$81.0011/30/18
UBSAnnouncesInitiates Coverage OnBuy$83.0011/28/18
*Last 90 days


Service NameTrader NamePosition TypeTarget %Target PriceTarget Date Issue Date
Swingers CornerAkemi MokotoBuy Long10.94 %Subscribe11/12/1911/12/18View
Akemi's LongsAkemi MokotoBuy Long10.80 %Subscribe11/12/1911/12/18View

This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.



SymbolService NamePosition TypeIssuePrice Target PriceClose Date% Return Comments
ABTIt's only moneyBuy Long$44.10$49.0006/19/1711.10 %CommentsView


CVS Health's (CVS) Q4 Earnings Top Estimates, Margins Up

CVS Health Corporation s CVS fourth quarter 2018 adjusted earnings per share EPS of 2 14 surged 11 5 year over year and exceeded the Zacks Consensus Estimate by 3 4 The quarter s adjusted EPS considered certain transaction and integration costs related to the recently closed acquisition

Intuitive Surgical Gets FDA Nod for Ion Endoluminal System

Intuitive Surgical Inc 160 ISRG announced that the U S FDA has granted 501 k clearance for the Ion endoluminal system to enable minimally invasive biopsy in the peripheral lung The company plans a limited rollout of the platform in the United States with customer shipments to

Notable ETF Outflow Detected - IYH, ABT, MDT, ABBV

Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares U S Healthcare ETF Symbol IYH where we have detected an approximate 68 2 million dollar outflow that s a 2 7 decrease week over week from 12 800

Medtronic (MDT) Beats on Q3 Earnings, Gross Margin Down

Medtronic plc 160 MDT reported third quarter fiscal 2019 adjusted earnings per share EPS of 1 29 beating the Zacks Consensus Estimate by 4 Adjusted earnings rose 10 3 year over year Adjustments in the quarter primarily included the impact of restructuring charges intangible

Medtronic Posts Prelim PRODIGY Outcome on Opioid Overdose

Medtronic plc MDT recently announced preliminary results from its long initiated PRODIGY study which is a global evaluation of opioid induced respiratory depression OIRD a preventable form of respiratory compromise The PRODIGY PR ediction of O pioid induced respiratory D epression I

Here's Why Investors Should Buy Surmodics (SRDX) Stock Now

Surmodics Inc SRDX is one of the top players in the MedTech space The company s impressive performance in first quarter fiscal 2019 and consistent focus on Research and Development R amp D are working in favor of the stock In a year s time this Zacks Rank 1 Strong Buy stock

Align Technology Unveils iTero Element 5D Imaging System

Expanding the iTero suite Align Technology Inc ALGN recently announced the launch of its first intraoral scanner with near infrared imaging NIRI technology iTero Element 5D Imaging System The company is planning to display the complete range of iTero products including the iTero

Cryolife (CRY) Earnings Miss, Revenues Top Estimates in Q4

CryoLife Inc CRY reported fourth quarter 2018 adjusted earnings per share EPS of 5 cents down 64 3 year over year This figure missed the Zacks Consensus Estimate by 58 33 On a reported basis the company saw loss of 5 cents a share narrower than the year ago loss of 9

Here's Why You Must Buy Cardiovascular Systems' (CSII) Stock

Cardiovascular Systems Inc CSII has been gaining investor confidence on continued positive results The company s share price has outperformed its 160 industry over the past year The stock has gained 46 9 in comparison to the industry s 4 2 rise and the S amp P 500 s 0 9 increase in

Johnson & Johnson (JNJ) to Acquire Auris Health for $3.4B

Johnson amp Johnson s JNJ robotic surgery and medical device division Ethicon entered into a definitive agreement to acquire Auris Health Inc a developer of robotic technologies focused on lung cancer for approximately 3 4 billion in cash If certain milestones are achieved Auris

Quest Diagnostics (DGX) Q4 Earnings in Line, Margins Down

Quest Diagnostics Incorporated s DGX fourth quarter 2018 adjusted earnings per share EPS of 1 36 were on par with the Zacks Consensus Estimate Adjusted earnings declined 1 4 from the year ago number Reported EPS came in at 92 cents reflecting a 49 5 decline from the year ago

Baxter's Acute Therapies Profile Strong, Competition Rife

On Feb 13 we issued an updated research report on Baxter International Inc BAX While solid Acute Therapies profile is a positive generic competition for Cyclophosphamide and lackluster sales in a few sub segments are key concerns The stock currently carries a Zacks Rank 3

Bio-Techne (TECH) Q2 Earnings Beat, Gross Margin Declines

Bio Techne Corporation TECH reported second quarter fiscal 2019 adjusted earnings per share EPS of 1 06 up 3 9 from the year ago quarter 160 This figure surpassed the Zacks Consensus Estimate by 6 Reported EPS in the quarter under review was 45 cents down 65 1 year over

Here's Why Investors Should Retain AmerisourceBergen Stock

AmerisourceBergen Corporation ABC is expected to benefit from its first quarter fiscal 2019 results and a strong Pharmaceutical Distribution unit However sluggishness in the MWI unit might hurt prospects Price Performance In a year s time shares of this Zacks Rank 3 Hold company

Boston Scientific Benefits From New Buyouts & Product Launch

On Feb 12 we issued an updated research report on Boston Scientific Corporation BSX The company s recent acquisitions have added various products though many are under development with immense potential to its portfolio The stock carries a Zacks Rank 3 Hold Over the past three

Abbott Laboratories Q4 18 Earnings Conference Call At 9:00 AM ET

Abbott Laboratories Q4 18 Earnings Conference Call At 9:00 AM ET

Abbott Sees Q1 Profit Below View

Abbott Sees Q1 Profit Below View